Ester M Hammond

Affiliations: 
University of Oxford, Oxford, United Kingdom 
Area:
Hypoxia
Google:
"Ester Hammond"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Wallabregue ALD, Bolland H, Faulkner S, et al. (2023) Two Color Imaging of Different Hypoxia Levels in Cancer Cells. Journal of the American Chemical Society. 145: 2572-2583
Koyasu S, Horita S, Saito K, et al. (2022) ZBTB2 links p53 deficiency to HIF-1-mediated hypoxia signaling to promote cancer aggressiveness. Embo Reports. e202154042
Sekirnik AR, Reynolds JK, See L, et al. (2022) Identification of Histone Peptide Binding Specificity and Small-Molecule Ligands for the TRIM33α and TRIM33β Bromodomains. Acs Chemical Biology
Suwa T, Kobayashi M, Shirai Y, et al. (2021) SPINK1 as a plasma marker for tumor hypoxia and a therapeutic target for radiosensitization. Jci Insight. 6
Troelsen KS, Calder EDD, Skwarska A, et al. (2021) Zap-Pano: a Photocaged pro-drug of the KDAC inhibitor panobinostat. Chemmedchem
Brand M, Clayton J, Moroglu M, et al. (2021) Controlling Intramolecular Interactions in the Design of Selective, High-Affinity Ligands for the CREBBP Bromodomain. Journal of Medicinal Chemistry
Bader SB, Ma TS, Simpson CJ, et al. (2021) Replication catastrophe induced by cyclic hypoxia leads to increased APOBEC3B activity. Nucleic Acids Research
Ramachandran S, Ma TS, Griffin J, et al. (2021) Hypoxia-induced SETX links replication stress with the unfolded protein response. Nature Communications. 12: 3686
Skwarska A, Calder EDD, Sneddon D, et al. (2021) Development and pre-clinical testing of a novel hypoxia-activated KDAC inhibitor. Cell Chemical Biology
Bowler E, Skwarska A, Wilson JD, et al. (2020) Pharmacological Inhibition of ATR Can Block Autophagy through an ATR-Independent Mechanism. Iscience. 23: 101668
See more...